Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
Oncotarget
|
February 5, 2017
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
Erika Maria Parasido, Alessandra Silvestri, Vincenzo Canzonieri, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 3, 2010
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
Alessandra Silvestri, Alfonso Colombatti, Valerie S Calvert, et al.
Cancer Reports (Hoboken, N.J.)
|
March 5, 2024
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy
Page E Blas, Esther San Roman Rodriguez, Heather L Williams, et al.
Clinical & Experimental Metastasis
|
October 12, 2012
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations
Alessandra Silvestri, Valerie Calvert, Claudio Belluco, et al.
Molecular Oncology
|
December 15, 2020
Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation
Xiaoliang Zhao, In-Kyu Kim, Bhaskar Kallakury, et al.
Cell Communication and Signaling : CCS
|
July 26, 2024
Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds
Claire E Blanchard, Alison T Gomeiz, Kyle Avery, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 22, 2021
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN
Marta Codrich, Emiliano Dalla, Catia Mio, et al.
Oncotarget
|
November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study
Vienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
Elisa Baldelli, Mahalakshmi Subramanian, Abduljalil M Alsubaie, et al.
Clinical Colorectal Cancer
|
June 5, 2012
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment
Enzo Mammano, Francesca Galdi, Mariaelena Pierobon, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
Oncotarget
|
February 5, 2017
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
Erika Maria Parasido, Alessandra Silvestri, Vincenzo Canzonieri, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 3, 2010
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
Alessandra Silvestri, Alfonso Colombatti, Valerie S Calvert, et al.
Cancer Reports (Hoboken, N.J.)
|
March 5, 2024
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy
Page E Blas, Esther San Roman Rodriguez, Heather L Williams, et al.
Clinical & Experimental Metastasis
|
October 12, 2012
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations
Alessandra Silvestri, Valerie Calvert, Claudio Belluco, et al.
Molecular Oncology
|
December 15, 2020
Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation
Xiaoliang Zhao, In-Kyu Kim, Bhaskar Kallakury, et al.
Cell Communication and Signaling : CCS
|
July 26, 2024
Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds
Claire E Blanchard, Alison T Gomeiz, Kyle Avery, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 22, 2021
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN
Marta Codrich, Emiliano Dalla, Catia Mio, et al.
Oncotarget
|
November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study
Vienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
Elisa Baldelli, Mahalakshmi Subramanian, Abduljalil M Alsubaie, et al.
Clinical Colorectal Cancer
|
June 5, 2012
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment
Enzo Mammano, Francesca Galdi, Mariaelena Pierobon, et al.
Page
of 10